Skip to main content
IONS logo

IONS · Ionis Pharmaceuticals Inc · Executive Compensation

Track IONS — free
$26.96 -1.05 (-3.75%) At close · Nov 17 Play latest call Q3 2026 earnings call transcript
Market Cap
$4.49B
Shares
166.55M
Volume · Nov 17 4.49M Avg daily vol (3M) 3.9M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2024
Executive Total
Mariana Baroldi $679,035
Fiscal 2023
Executive Total
Mariana Baroldi $513,949
Fiscal 2022
Executive Total
Mariana Baroldi $370,238
Grant Swayze $68,951
Fiscal 2021
Executive Total
Elizabeth Hougen $4,128,329
Patrick R. O’Neil $3,923,145
Onaiza Cadoret-Manier $3,665,966
Eric Swayze $3,619,450
Fiscal 2020
Executive Total
Elizabeth Hougen $4,341,100
Patrick R. O’Neil $3,965,065
Onaiza Cadoret-Manier $3,504,442
Eric Swayze $2,342,700
Fiscal 2019
Executive Total
Brett Monia $6,527,963
Elizabeth Hougen $3,481,858
Patrick R. O’Neil $3,463,901
Eric Swayze $2,112,032

Executive changes

Person Change Filed
Ludwig N. Hantson Appointed 2026-06-08
Joseph H. Wender Retired 2026-03-09
Peter N. Reikes Appointed 2026-03-09
B. Lynne Parshall Retired 2026-03-09
Holly Kordasiewicz, Ph.D. Appointed 2025-06-12
Richard Geary Ph.D. Retired 2025-06-12
Michael Yang Appointed 2023-12-14
Frederick Muto Retired 2022-07-18

Leadership

Key facts CIK 874015 CUSIP 462222100 13F (30d) 483 filings 437 filers Visit website Investor relations